CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Propranolol oral solution

Last Updated: July 27, 2016
Result type: Reports
Project Number: SR0496-000
Product Line: Reimbursement Review

Generic Name: Propranolol oral solution

Brand Name: Hemangiol

Manufacturer: Pierre Fabre Dermo-Cosmétique

Therapeutic Area: Infantile hemangioma

Indications: Infantile hemangioma

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: February 21, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions